Kalincik, T. Et Al. 2017. Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 361-363.

Kalincik, T., Spelman, T., Jokubaitis, V., Horakova, D., Havrdova, E., Trojano, M., ... Sola, P.(2017). Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.361-363). Paris, France

Kalincik, T. Et Al. "Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017

Kalincik, T. Et Al. "Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.361-363, 2017

Kalincik, T. Et Al. (2017) . "Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.361-363.

@conferencepaper{conferencepaper, author={T. Kalincik Et Al. }, title={Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={361-363} }